PharmaSafe at ICPE 2022!

A team of the PharmaSafe group traveled to Copenhagen to join the 38th International Conference on PharmacoEpidemiology (ICPE 2022).

We were excited to listen to cutting-edge research on “Advancing Pharmacoepidemiology and Real-World Evidence for the Global Community”. The team contributed with three oral presentations and twelve posters, met collaboration partners from ongoing international projects, such as IMI-ConcePTION and CONSIGN, and participated in the Special Interest Group Meeting on Medication in Pregnancy and Lactation (MiPal). 

Image may contain: Product, Technology, Projection screen, Display device, Electronic device.
We had three talks and twelve poster presentations during the ICPE 2022 conference. Photos: private.
We enjoyed the conference, meeting collaborators and having fun at the Congress Party. Photos: private.

Organization of one symposium with an oral presentation

Hedvig Nordeng: Meeting the Need for Research on Drug Safety During Lactation: An Overview of Approaches – symposium on Drug Safety During Lactation Symposium

Oral presentations

Angela Lupattelli: Association of Prenatal Antidepressant Exposure with Trajectories and Acceleration of Body Mass Index in Children from 6 Week to 8 Years of Age

Nhung Thi Hong Trinh: Antidepressant Treatment in Pregnancy and Maternal Mental Health in the Postpartum Year: A Danish Registry Linkage Study in Pregnant Women with Obsessive‐compulsive Disorder

Posters

Angela Lupattelli et al.: Antidepressant Continuation and Adherence in Pregnancy and Risk of Antenatal Hospital Admission for Depression and/or Anxiety – Selected for Spotlight Poster Session

Eimir Hurley et al.: COVID-19 Infection and Medication Use in Pregnancy (CONSIGN) – A Multinational Drug Utilisation Study Using Linked Healthcare Data – Selected for Spotlight Poster Session

Nhung Trinh et al.: Association Between Antidepressant Use Patterns on The Long-Term Trajectories of Depressive and Anxiety Symptoms and Health-Related Quality of Life

Nhung Trinh et al.: Postpartum Episode of Eating, Mood, or Anxiety Disorder in Women with Eating Disorders Who Continue or Discontinue Antidepressant Treatment in Pregnancy

Angela Lupattelli et al.:  Decisional Conflicts About Antidepressant Treatment in Pregnant Women in Norway

Angela Lupattelli et al.:  Prenatal Exposure to Antidepressants and Risk of Overweight and Obesity in Offspring at Age 8 Years

Fatima Tauqeer et al.: Barriers and Enablers of Decision-Making Considering Use of Antidepressants – A Mixed-Method Study Among Pregnant and Postpartum Women with a Mental Illness

Ugochinyere Vivian Ukah et al.: Trends in Cardiovascular Medication Prescription Before and During the COVID-19 Pandemic

Mollie Wood et al.: Methodologic Considerations for Emulating Target Trial for Discontinuation of Antidepressant Treatment in Pregnancy

Co-authoring posters

Hedvig Nordeng and Eimir Hurley: COVID-19 Related Drug Utilization Study in Pregnancy – The COVI-Preg Cohort

Hedvig Nordeng and Eimir Hurley: Extracting Pregnancies from Heterogeneous Data Sources in Europe: A Novel Algorithm in The Conception Project

Angela Lupatelli: VAC4EU Active Safety Surveillance Study of The BNT162b2 COVID-19 Vaccine in Five European Countries: Study Design and First Results

Published Aug. 31, 2022 5:49 PM - Last modified Sep. 4, 2022 1:19 PM